NOS2 and neoplasm: Notably, Arg1 expression in TAMs and tumors can be inhibited with PI3Kγ inhibitors, and PI3Kγ deletion promotes the development of NOS, which may accelerate the creation of tumor-killing NO from L-arginine [141, 144].